These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33063421)

  • 1. The airway microbiome in COPD, bronchiectasis and bronchiectasis-COPD overlap.
    Tiew PY; Jaggi TK; Chan LLY; Chotirmall SH
    Clin Respir J; 2021 Feb; 15(2):123-133. PubMed ID: 33063421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Frequency of Allergic Bronchopulmonary Aspergillosis in Bronchiectasis-COPD Overlap.
    Tiew PY; Lim AYH; Keir HR; Dicker AJ; Mac Aogáin M; Pang SL; Low TB; Hassan TM; Poh ME; Xu H; Ong TH; Koh MS; Abisheganaden JA; Tee A; Chew FT; Chalmers JD; Chotirmall SH
    Chest; 2022 Jan; 161(1):40-53. PubMed ID: 34364870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical impacts of lung microbiome in bronchiectasis with fixed airflow obstruction: a prospective cohort study.
    Chen YF; Hou HH; Chien N; Lu KZ; Lin CH; Liao YC; Lor KL; Chien JY; Chen CM; Chen CY; Cheng SL; Wang HC; Hsueh PR; Yu CJ
    Respir Res; 2024 Aug; 25(1):308. PubMed ID: 39143556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease.
    Mac Aogáin M; Lau KJX; Cai Z; Kumar Narayana J; Purbojati RW; Drautz-Moses DI; Gaultier NE; Jaggi TK; Tiew PY; Ong TH; Siyue Koh M; Lim Yick Hou A; Abisheganaden JA; Tsaneva-Atanasova K; Schuster SC; Chotirmall SH
    Am J Respir Crit Care Med; 2020 Aug; 202(3):433-447. PubMed ID: 32320621
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased Chitotriosidase Is Associated With Aspergillus and Frequent Exacerbations in South-East Asian Patients With Bronchiectasis.
    Poh TY; Tiew PY; Lim AYH; Thng KX; Binte Mohamed Ali NA; Narayana JK; Mac Aogáin M; Tien Z; Chew WM; Wai Chan AK; Keir HR; Dicker AJ; Hassan TM; Xu H; Tee AKH; Ong TH; Koh MS; Abisheganaden JA; Chalmers JD; Chotirmall SH
    Chest; 2020 Aug; 158(2):512-522. PubMed ID: 32184111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting respiratory microbiomes in COPD and bronchiectasis.
    Mac Aogáin M; Tiew PY; Jaggi TK; Narayana JK; Singh S; Hansbro PM; Segal LN; Chotirmall SH
    Expert Rev Respir Med; 2024; 18(3-4):111-125. PubMed ID: 38743428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of sputum microbiome studies identifies airway disease-specific taxonomic and functional signatures.
    Ghosh A; Saha S
    J Med Microbiol; 2022 Dec; 72(12):. PubMed ID: 36748565
    [No Abstract]   [Full Text] [Related]  

  • 8. The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease.
    Tiew PY; Mac Aogáin M; Chotirmall SH
    Curr Opin Pulm Med; 2022 Mar; 28(2):121-133. PubMed ID: 34839338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alterations of oral, airway and intestine microbiota in chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Kou Z; Liu K; Qiao Z; Wang Y; Li Y; Li Y; Yu X; Han W
    Front Immunol; 2024; 15():1407439. PubMed ID: 38779669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the "Chronic Obstructive Pulmonary Disease-Bronchiectasis Association".
    Huang JT; Cant E; Keir HR; Barton AK; Kuzmanova E; Shuttleworth M; Pollock J; Finch S; Polverino E; Bottier M; Dicker AJ; Shoemark A; Chalmers JD
    Am J Respir Crit Care Med; 2022 Aug; 206(4):417-426. PubMed ID: 35436182
    [No Abstract]   [Full Text] [Related]  

  • 11. Adiponectin Increase in Patients Affected by Chronic Obstructive Pulmonary Disease with Overlap of Bronchiectasis.
    Nigro E; Mosella M; Daniele A; Mallardo M; Accardo M; Bianco A; Perrotta F; Scialò F
    Life (Basel); 2023 Feb; 13(2):. PubMed ID: 36836801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study.
    Dicker AJ; Lonergan M; Keir HR; Smith AH; Pollock J; Finch S; Cassidy AJ; Huang JTJ; Chalmers JD
    Lancet Respir Med; 2021 Aug; 9(8):885-896. PubMed ID: 33961805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airway "Resistotypes" and Clinical Outcomes in Bronchiectasis.
    Mac Aogáin M; Ivan FX; Jaggi TK; Richardson H; Shoemark A; Narayana JK; Dicker AJ; Koh MS; Lee KCH; Thun How O; Poh ME; Chin KK; Hou ALY; Ser Hon P; Low TB; Abisheganaden JA; Dimakou K; Digalaki A; Kosti C; Gkousiou A; Hansbro PM; Blasi F; Aliberti S; Chalmers JD; Chotirmall SH
    Am J Respir Crit Care Med; 2024 Jul; 210(1):47-62. PubMed ID: 38271608
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
    Yang CY; Li SW; Chin CY; Hsu CW; Lee CC; Yeh YM; Wu KA
    J Transl Med; 2021 Mar; 19(1):121. PubMed ID: 33757530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease.
    Dicker AJ; Huang JTJ; Lonergan M; Keir HR; Fong CJ; Tan B; Cassidy AJ; Finch S; Mullerova H; Miller BE; Tal-Singer R; Chalmers JD
    J Allergy Clin Immunol; 2021 Jan; 147(1):158-167. PubMed ID: 32353489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
    Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
    Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucolytic Agents and Statins Use is Associated with a Lower Risk of Acute Exacerbations in Patients with Bronchiectasis-Chronic Obstructive Pulmonary Disease Overlap.
    Su VY; Perng DW; Chou TC; Chou YC; Chang YL; Hsu CC; Chou CL; Lee HC; Chen TJ; Hu PW
    J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30518165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory Mycoses in COPD and Bronchiectasis.
    Tiew PY; Mac Aogáin M; Ter SK; Aliberti S; Chalmers JD; Chotirmall SH
    Mycopathologia; 2021 Oct; 186(5):623-638. PubMed ID: 33709335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles.
    Ghebre MA; Pang PH; Diver S; Desai D; Bafadhel M; Haldar K; Kebadze T; Cohen S; Newbold P; Rapley L; Woods J; Rugman P; Pavord ID; Johnston SL; Barer M; May RD; Brightling CE
    J Allergy Clin Immunol; 2018 Jun; 141(6):2027-2036.e12. PubMed ID: 29709671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lung microbiome and exacerbations of COPD.
    Dy R; Sethi S
    Curr Opin Pulm Med; 2016 May; 22(3):196-202. PubMed ID: 26964078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.